Dose adjustment in renal impairment
Dose adjustment may be needed in kidney disease.
Leaflet VALSARTAN/HIDROCLOROTIAZIDA KRKA 160mg / 12.5mg film-coated tablets
- Product code:
- W56726004
- Quantity:
- 56
- Indicated for:
- hypertension
- Route of administration:
- oral
- Substance:
- valsartan + hydrochlorothiazide (angiotensin II receptor blocker + diuretic)
- ATC
- C09DA03 — Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics
Precautions:
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Photosensitivity
Avoid excessive exposure to sunlight or UV radiation.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
The combination of valsartan and hydrochlorothiazide is used for the treatment of hypertension, particularly in patients who do not respond adequately to monotherapy. Valsartan is an angiotensin II receptor blocker (ARB) that relaxes blood vessels and lowers blood pressure by blocking the effects of angiotensin II. Hydrochlorothiazide is a thiazide diuretic that helps eliminate excess salt and water from the body, thereby reducing blood pressure.
This combination is administered orally, usually once daily, and the dosage is adjusted based on the patient's response and blood pressure levels. It is important for patients to adhere to the treatment and regularly monitor their blood pressure.
Common side effects include dizziness, headaches, fatigue, and hypokalemia. In rare cases, severe adverse reactions such as renal failure, hyponatremia, or allergic reactions may occur.
The combination of valsartan and hydrochlorothiazide provides an effective option for managing hypertension, helping to reduce the risk of cardiovascular complications such as myocardial infarction or stroke.
This combination is administered orally, usually once daily, and the dosage is adjusted based on the patient's response and blood pressure levels. It is important for patients to adhere to the treatment and regularly monitor their blood pressure.
Common side effects include dizziness, headaches, fatigue, and hypokalemia. In rare cases, severe adverse reactions such as renal failure, hyponatremia, or allergic reactions may occur.
The combination of valsartan and hydrochlorothiazide provides an effective option for managing hypertension, helping to reduce the risk of cardiovascular complications such as myocardial infarction or stroke.
General data about VALSARTAN/HIDROCLOROTIAZIDA KRKA 160mg / 12.5mg
- Substance:
- valsartan + hydrochlorothiazide
- Date of latest medicines list:
- 01-07-2013
- Product code:
- W56726004
- Concentration:
- 160mg / 12.5mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 56
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for valsartan + hydrochlorothiazide
- 160mg/12.5mg
- 160mg/25mg
- 320mg/12.5mg
- 320mg/25mg
- 80mg/12.5mg